期刊文献+

血清前白蛋白、胆碱酯酶与肝组织病理损害的相关性研究 被引量:6

Relationship between serum prealbumin,cholinesterase and pathological injury of hepatic tissue
暂未订购
导出
摘要 目的:探讨各类肝炎患者血清前白蛋白(PA)、胆碱酯酶(ChE)和透明质酸(HA)、层粘蛋白(LN)、Ⅳ型胶原(IVC)、Ⅲ型前胶原氨端肽(PⅢNP)等血清肝纤维化指标与肝组织病理损害的相关性。方法:观察292例经肝活检证实的各类肝炎患者血清PA、ChE水平和血清肝纤维化指标的变化,并将其与肝组织活检的炎症分级和纤维化分期进行相关性分析。结果:肝脏病理组织炎症分为G1~G4级,纤维化分为S0~S4期。炎症轻重两组间PA、ChE和血清肝纤维化指标差异均有显著性(P<0.01)。随着纤维化程度的增加,PA、ChE逐渐下降,而血清肝纤维化指标逐渐升高,且S4与S0~S3比较差异有显著性(P<0.01)。PA、ChE和血清肝纤维化指标与炎症分级及纤维化分期之间的相关性均非常显著(P<0.01)。结论:PA、ChE和血清肝纤维化指标能较好地反映肝脏的炎症活动水平且能较敏感地反映肝脏的纤维化程度,联合检测有可能成为较好的无创性诊断方法。 Objective To investigate the relationship between serum prealbumin (PA), cholinesterase (ChE), fibrosis markers and pathological injury of hepatic tissue in patients with all kinds of hepatitis. Methods Detection of serum PA, ChE and serum fibrosis markers together with liver biopsy was performed in 292 patients with hepatitis. The relationship between those serum components and the grade of inflammation, fibrosis staging in hepatic tissue was analyzed. Results There was a significant difference of PA, ChE and fibrosis markers between the lower grade and higher grade of inflammation ( P 〈 0. 01 ). Serum PA and ChE were gradually decreased but fibrosis markers elevated with the progression of hepatic fibrosis, making a marked difference between fibrosis S0 - S3 and S4 ( P 〈 0. 01 ). The relationship between serum PA, ChE, fibrosis markers and the grade of inflammation, fibrosis staging was highly significant ( P 〈 0. 01). Conclusions Serum PA, ChE and fibrosis markers can signal the level d liver inflammation activity and the extent of hepatic fibrosis. Combined detection of PA, ChE and fibrosis markers may he a noninvasive diagnostic method for the severity of hepatitis.
出处 《实用医学杂志》 CAS 2006年第15期1732-1734,共3页 The Journal of Practical Medicine
关键词 肝硬化 前白蛋白 胆碱酯酶类 Liver cirrhosis Prealbumin Cholinesterases
  • 相关文献

参考文献7

二级参考文献48

  • 1李伟道.肝纤维化血清标志物的新进展[J].国外医学(临床生物化学与检验学分册),1994,15(1):3-6. 被引量:27
  • 2病毒性肝炎防治方案(试行)[J].中华传染病杂志,1995,13(4):241-247. 被引量:1767
  • 3邹正升 辛绍杰 等.胆碱酯酶、γ-球蛋白及胆固醇与肝组织病理损害的关系[J].中华肝脏病杂志,1999,7:66-66.
  • 4邓岩,刘小平.血清胆碱脂酶活力测定对慢性肝炎诊治的临床意义[J].重庆医学,1997,26(1):16-17. 被引量:23
  • 5Kondo M, Hada T, Fukui T, et al. Enzyme-linked immunosorbent assay(ELISA)for Aleuria aurantia lectinreactive serum cholinesterase to differentiate livw cirrhosis and chronic hepa-titis . Chin Chim Acta, 1995, 243:1-9.
  • 6Afdhal NH. Diagnosing fibrosis in hepatitis C: is the pendulum swinging from biopsy to blood tests? Hepatology,2003,37:972-974.
  • 7Giannini E, Testa R. Noninvasive diagnosis of fibrosis: the truth is rarely pure and never simple. Hepatology,2003,38:1312-1131.
  • 8Poynard T,Munteanu M,Imbert-Bismut F,et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem,2004,50:1344-1355.
  • 9Fontana RJ,Lok AS. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology,2002,36:S57-S64.
  • 10McCaughan GW,George J. Fibrosis progression in chronic hepatitis C virus infection. Gut,2004,53:318-321.

共引文献136

同被引文献41

引证文献6

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部